Economic cost of advanced liver disease
Tuesday, November 8, 2011 - 22:30
in Health & Medicine
Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a new study. Although infection with the hepatitis C virus increases health care costs overall, the specific impact of the disease's progressive severity on health care costs has previously not been well studied.